These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 38579099

  • 21. Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence.
    Rieken M, Kluth LA, Fajkovic H, Capitanio U, Briganti A, Krabbe LM, Margulis V, Abufaraj M, Mari A, Foerster B, Raman JD, Regelman M, Brookman-May S, Sjoberg DD, Karakiewicz PI, Shariat SF.
    Clin Genitourin Cancer; 2018 Aug; 16(4):e903-e908. PubMed ID: 29653814
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma?
    Palacios DA, Zabor EC, Munoz-Lopez C, Roversi G, Mahmood F, Abramczyk E, Kelly M, Wilson B, Abouassaly R, Campbell SC.
    Eur Urol; 2021 Jun; 79(6):774-780. PubMed ID: 33678521
    [Abstract] [Full Text] [Related]

  • 24. Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.
    Palumbo C, Mistretta FA, Knipper S, Mazzone E, Pecoraro A, Tian Z, Perrotte P, Antonelli A, Montorsi F, Shariat SF, Saad F, Simeone C, Briganti A, Lavallee LT, Karakiewicz PI.
    Minerva Urol Nefrol; 2020 Jun; 72(3):350-359. PubMed ID: 31487976
    [Abstract] [Full Text] [Related]

  • 25. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
    Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, Thapa P, Boorjian SA.
    Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
    [Abstract] [Full Text] [Related]

  • 26. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
    Abu-Ghanem Y, Powles T, Capitanio U, Beisland C, Järvinen P, Stewart GD, Gudmundsson E, Lam TBL, Marconi L, Fernandéz-Pello S, Nisen H, Meijer RP, Volpe A, Ljungberg B, Klatte T, Bensalah K, Dabestani S, Bex A.
    BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
    [Abstract] [Full Text] [Related]

  • 27. Prognostic Significance of Preoperative Anemia in Patients Undergoing Surgery for Renal Cell Carcinoma: A Meta-analysis.
    Xia L, Hu G, Guzzo TJ.
    Anticancer Res; 2017 Jun; 37(6):3175-3181. PubMed ID: 28551661
    [Abstract] [Full Text] [Related]

  • 28. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
    Sun M, Trinh QD, Bianchi M, Hansen J, Abdollah F, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI.
    BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
    [Abstract] [Full Text] [Related]

  • 29. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC, Derweesh I, Porpiglia F, Zargar H, Mottrie A, Autorino R.
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [Abstract] [Full Text] [Related]

  • 30. Clinical significance of prognostic nutritional index in renal cell carcinomas.
    Tang Y, Liang J, Liu Z, Zhang R, Zou Z, Wu K, Lu Y, Wei X.
    Medicine (Baltimore); 2021 Mar 12; 100(10):e25127. PubMed ID: 33725913
    [Abstract] [Full Text] [Related]

  • 31. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y, Ramon J, Berger R, Kaver I, Fridman E, Leibowitz-Amit R, Dotan ZA.
    World J Surg Oncol; 2017 Nov 02; 15(1):193. PubMed ID: 29096642
    [Abstract] [Full Text] [Related]

  • 32. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
    Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A, PROMETRICS 2011 Study Group.
    BJU Int; 2018 Jan 02; 121(1):101-110. PubMed ID: 28905486
    [Abstract] [Full Text] [Related]

  • 33. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
    Capitanio U, Stewart GD, Klatte T, Akdogan B, Roscigno M, Marszalek M, Dell'Oglio P, Zaffuto E, Rodriguez Faba O, Salagierski M, Lingard J, Carini M, Ouzaid I, Mir MC, Montorsi F, Da Pozzo LF, Stief C, Minervini A, Brookman-May SD.
    Eur Urol Focus; 2018 Dec 02; 4(6):972-977. PubMed ID: 28753867
    [Abstract] [Full Text] [Related]

  • 34. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy.
    Marchioni M, Bandini M, Pompe RS, Martel T, Tian Z, Shariat SF, Kapoor A, Cindolo L, Briganti A, Schips L, Capitanio U, Karakiewicz PI.
    BJU Int; 2018 Mar 02; 121(3):383-392. PubMed ID: 28940649
    [Abstract] [Full Text] [Related]

  • 35. The impact of perioperative blood transfusion on survival and recurrence after radical prostatectomy for prostate cancer: A systematic review and meta-analysis.
    Pushan Z, Manbiao C, Sulai L, Jun L, Ruidong Z, Hanshen Y.
    J Cancer Res Ther; 2018 Sep 02; 14(Supplement):S701-S707. PubMed ID: 30249890
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD, May M, Wolff I, Zigeuner R, Hutterer GC, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Feciche B, Figenshau RS, Madison K, Sánchez-Chapado M, Santiago Martin Mdel C, Salzano L, Lotrecchiano G, Zastrow S, Wirth M, Sountoulides P, Shariat S, Waidelich R, Stief C, Gunia S, CORONA Project, European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group.
    Eur Urol; 2015 May 02; 67(5):943-51. PubMed ID: 25684695
    [Abstract] [Full Text] [Related]

  • 37. The prognostic value of the Controlling Nutritional Status score on patients undergoing nephrectomy for upper tract urothelial carcinoma or renal cell carcinoma: a systematic review and meta-analysis.
    Chen J, Cao D, Peng Z, Song P, Liu Z, Yang L, Wang L, Zhou J, Wei Q, Dong Q.
    Br J Nutr; 2022 Jul 28; 128(2):217-224. PubMed ID: 34338171
    [Abstract] [Full Text] [Related]

  • 38. Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy.
    Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Tappero S, Tian Z, Kokorovic A, Larcher A, Capitanio U, Tilki D, Terrone C, Chun FKH, Antonelli A, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI.
    Eur Urol Focus; 2023 Jan 28; 9(1):125-132. PubMed ID: 35918270
    [Abstract] [Full Text] [Related]

  • 39. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
    Marchioni M, Preisser F, Bandini M, Nazzani S, Tian Z, Kapoor A, Cindolo L, Abdollah F, Tilki D, Briganti A, Montorsi F, Shariat SF, Schips L, Karakiewicz PI.
    Eur Urol Focus; 2019 May 28; 5(3):467-473. PubMed ID: 29398456
    [Abstract] [Full Text] [Related]

  • 40. Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.
    Diamantopoulos LN, Sekar RR, Holt SK, Khaki AR, Miller NJ, Gadzinski A, Nyame YA, Vakar-Lopez F, Tretiakova MS, Psutka SP, Gore JL, Lin DW, Schade GR, Hsieh AC, Lee JK, Yezefski T, Schweizer MT, Cheng HH, Yu EY, True LD, Montgomery RB, Grivas P, Wright JL.
    Urol Oncol; 2021 Aug 28; 39(8):496.e1-496.e8. PubMed ID: 33551249
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.